These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 2930027)
1. Effect of clindamycin on factor-VII activity in healthy cats. Jacobs G; Lappin M; Marks A; Greene CE Am J Vet Res; 1989 Mar; 50(3):393-5. PubMed ID: 2930027 [TBL] [Abstract][Full Text] [Related]
2. Vitamin K-dependent blood clotting changes in female rats treated with oestrogens. Hart JE Thromb Haemost; 1987 Jun; 57(3):273-7. PubMed ID: 2821645 [TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous administration of T-2 toxin on blood coagulation in calves. Gentry PA; Cooper ML Am J Vet Res; 1983 May; 44(5):741-6. PubMed ID: 6869975 [TBL] [Abstract][Full Text] [Related]
4. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. Nelson RW; Feldman EC; Ford SL; Roemer OP J Am Vet Med Assoc; 1993 Sep; 203(6):821-7. PubMed ID: 8226235 [TBL] [Abstract][Full Text] [Related]
5. Randomized, Controlled, Crossover trial of Prevention of Clindamycin-Induced Gastrointestinal Signs Using a Synbiotic in Healthy Research Cats. Stokes JE; Price JM; Whittemore JC J Vet Intern Med; 2017 Sep; 31(5):1406-1413. PubMed ID: 28755457 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic and toxic plasma concentrations of digoxin in the cat. Erichsen DF; Harris SG; Upson DW Am J Vet Res; 1980 Dec; 41(12):2049-58. PubMed ID: 7212438 [TBL] [Abstract][Full Text] [Related]
7. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781 [TBL] [Abstract][Full Text] [Related]
8. Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. Burns P; Hoffman CJ; Katz JP; Miller RH; Lawson WE; Hultin MB J Lab Clin Med; 1993 Dec; 122(6):720-7. PubMed ID: 8245691 [TBL] [Abstract][Full Text] [Related]
9. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats]. Mischke R; Deniz A; Nolte I Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficiency impairs blood clotting and reduces factor VII coagulant activity in rat. Sävendahl LS; Grankvist K; Engström KG Thromb Haemost; 1995 Apr; 73(4):626-9. PubMed ID: 7495070 [TBL] [Abstract][Full Text] [Related]
11. Ketoconazole for treatment of dermatophytosis in cats. Medleau L; Chalmers SA J Am Vet Med Assoc; 1992 Jan; 200(1):77-8. PubMed ID: 1537696 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia. Moore AS; Ruslander D; Cotter SM; Rand WM; L'Heureux DA J Am Vet Med Assoc; 1995 May; 206(10):1550-4. PubMed ID: 7775231 [TBL] [Abstract][Full Text] [Related]
13. A plasma factor enhances activity of vitamin K-dependent coagulation proteins. Owens MR; Cimino CD Thromb Haemost; 1983 Oct; 50(3):749-52. PubMed ID: 6648895 [TBL] [Abstract][Full Text] [Related]
14. [The plasma coagulation system of domestic cats]. Lutze G; Kutschmann K Berl Munch Tierarztl Wochenschr; 1991 Feb; 104(2):53-7. PubMed ID: 2025216 [TBL] [Abstract][Full Text] [Related]
15. Influence of warfarin therapy on activated factor VII clotting activity. Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262 [TBL] [Abstract][Full Text] [Related]
16. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. Ogilvie GK; Moore AS; Obradovich JE; Elmslie RE; Vail DM; Straw RC; Salmon MD; Klein MK; Atwater SW; Ciekot PE J Am Vet Med Assoc; 1993 Jun; 202(11):1839-44. PubMed ID: 8320152 [TBL] [Abstract][Full Text] [Related]
17. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants. Liu J; Wang Q; Gao F; He JW; Zhao JH J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625 [TBL] [Abstract][Full Text] [Related]
18. Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Bladbjerg EM; Tholstrup T; Marckmann P; Sandström B; Jespersen J Thromb Haemost; 1995 Feb; 73(2):239-42. PubMed ID: 7792736 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states. Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387 [TBL] [Abstract][Full Text] [Related]
20. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation. Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]